Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationRecurrenceHematopoiesisCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionTreatment OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingRetrospective StudiesBone Marrow NeoplasmsTransplantation ImmunologyAcute DiseaseGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionStem Cell TransplantationLymphocyte DepletionLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationSurvival AnalysisSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisHematologic DiseasesCyclosporineBone DensityFollow-Up StudiesLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilySurvival RateCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectCell DifferentiationLeukocyte CountGraft vs Leukemia EffectCytarabineCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalMice, Inbred BALB CEtoposideLymphomaFlow CytometryMultiple MyelomaPrognosisFatal OutcomeCells, CulturedProspective StudiesInfectionPostoperative ComplicationsAntigens, CD34Hodgkin DiseaseMice, KnockoutCell Transplantation